CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...
(HealthDay News) — Preventive psychological interventions may be effective for adults with subthreshold depressive symptoms, according to a review published online in the December issue of The Lancet ...
Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...
Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...
The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...
A one-time nasal spray has been approved by the Food and Drug Administration as a standalone treatment for depression.